Thrombolysis after acute myocardial infarction.
Preview Physicians know that thrombolysis has marked benefits in patients with certain classic findings after acute myocardial infarction. However, some do not realize that thrombolysis has relatively limited risks and can be administered to many more patients than it is at present. The authors review current indications and contraindications and summarize results of major clinical studies that compare currently available thrombolytic agents.